24 May 2013
Keywords: xenova, initiates, ph, iib, trial, ta-cd, uk
Article | 03 November 2003
UK biopharmaceutical company Xenova has initiated the first randomized,placebo-controlled Phase IIb clinical trial of TA-CD, its therapeutic
vaccine under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 March 2004
23 May 2013
© 2013 thepharmaletter.com